• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
XNCR

XNCR

Xencor, Inc.

NASDAQHealthcareBiotechnologyUS

USD11.42

+0.21 (+1.87%)

Rating:C-

Company Profile

CEO

Bassil I. Dahiyat

IPO Date

2013-12-03

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$11.30

Prev. Close

$11.21

Day Low

$11.23

Day High

$11.44

52W Low

$6.92

52W High

$18.69

Market Cap

$0.85B

Volume

0.59M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentNeutral

Articles

10

Avg Positive

26.5%

Avg Negative

20.8%

Avg Neutral

52.7%

News Feed

Xencor to Host Second Quarter 2021 Financial Results Webcast and Conference Call on August 4, 2021

Business Wire·7/28/2021·↑ positive

Down 10.9% in 4 Weeks, Here's Why Xencor (XNCR) Looks Ripe for a Turnaround

Zacks Investment Research·7/27/2021·↓ negative

5 Mid-Cap Healthcare Stocks You'll Want on Your Radar for the 2nd Half of 2021

The Motley Fool·7/23/2021·↑ positive

Xencor (XNCR) Loses 12.1% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Zacks Investment Research·6/30/2021·↓ negative

Sotrovimab (VIR-7831), an Investigational Antibody Utilizing Xencor's Xtend™ Technology, Receives U.S. FDA Emergency Use Authorization for the Treatment of COVID-19

Business Wire·5/26/2021·↑ positive

Xencor, Inc. (XNCR) CEO Bassil Dahiyat on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/8/2021·↓ negative

Xencor (XNCR) Reports Q1 Loss, Tops Revenue Estimates

Zacks Investment Research·5/5/2021·↑ positive

Xencor to Present Preclinical Data from Four Preclinical XmAb® Bispecific Antibody and Cytokine Programs at the American Association for Cancer Research (AACR) Annual Meeting 2021

Business Wire·3/10/2021·↑ positive

Xencor and UCLA Enter Collaboration to Discover and Develop Novel XmAb® Therapeutics

Business Wire·2/25/2021·↑ positive

Xencor Inc (XNCR) CEO Bassil Dahiyat on Q4 2020 Results - Earnings Call Transcript

Seeking Alpha·2/24/2021·↓ negative